UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000022148
Receipt number R000025518
Scientific Title Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression: a preliminary study
Date of disclosure of the study information 2016/05/09
Last modified on 2018/10/03 13:48:05

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression: a preliminary study

Acronym

Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression

Scientific Title

Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression: a preliminary study

Scientific Title:Acronym

Transcranial magnetic stimulation (TMS) in the treatment of refractory bipolar depression

Region

Japan


Condition

Condition

Bipolar depression

Classification by specialty

Psychiatry

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To examine the efficacy and tolerability of low-frequency right prefrontal transcranial magnetic stimulation in treatment-resistant bipolar depression and to identify a biological marker about its treatment response

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Changes in the total score of Hamilton's Rating Scale for Depression (HAMD 17 items) at week 4

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Low-frequency right prefrontal transcranial magnetic stimulation for 4 weeks

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >=

Gender

Male and Female

Key inclusion criteria

1. DSM-5 diagnosis of bipolar disorder, major depressive disorder
2. HAMD 17 score >= 18
3. Current episode duration < 3 y
4. Patient does not respond to the medications described below for more than 8 weeks.
i. Lithium, 0.8mmol/L
ii. Quetiapine, 300mg/day
iii. Olanzapine, 5-20mg/day
iv. Lamotrigine, 200mg/day

Key exclusion criteria

1. Rapid cycler type
2. Patient has a history of psychotic episode, OCD, PTSD, and eating disorder.
3. Patient had a previous treatment with ECT, TMS, VNS, DBS, and tDCS within 6 months.
4. Patient did not respond to ECT and TMS previously.
5. Pregnancy
6. Patient has a history of epilepsy and convulsion. Personal or close family history of seizure disorder
7. Neurologic disorder, organic brain disease
8. Substance or alcohol dependence
9. Ferromagnetic material in body or close to head
10. Severe metabolic disease, endocrine disease
11. Active suicide idea
12. Taking medications known to lower seizure threshold

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shinsuke Kito

Organization

National Center Hospital, National Center of Neurology and Psychiatry

Division name

Department of Psychiatry and Advanced Medical Technology

Zip code


Address

4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, Japan

TEL

042-341-2711

Email

kito@ncnp.go.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shinsuke Kito

Organization

National Center of Neurology and Psychiatry

Division name

Department of Psychiatry and Advanced Medical Technology

Zip code


Address

4-1-1 Ogawa-Higashi, Kodaira, Tokyo 187-8551, Japan

TEL

042-341-2711

Homepage URL


Email

kito@ncnp.go.jp


Sponsor or person

Institute

National Center Hospital, National Center of Neurology and Psychiatry

Institute

Department

Personal name



Funding Source

Organization

1. Fiduciary funding by Inter Reha Co.,Ltd
2. Self funding

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2016 Year 05 Month 09 Day


Related information

URL releasing protocol


Publication of results

Published


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2016 Year 04 Month 20 Day

Date of IRB


Anticipated trial start date

2016 Year 05 Month 09 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2016 Year 04 Month 30 Day

Last modified on

2018 Year 10 Month 03 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025518


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name